NDC 10122-210 – Myalept

Metreleptin 11.3 mg/2.2mL · Injection, Powder, Lyophilized, For Solution · Subcutaneous

Human Prescription Drug

Product NDC10122-210

Product details

Brand name
Myalept
Generic name
Metreleptin
Labeler
Chiesi USA, Inc.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Subcutaneous
Marketing category
BLA · BLA125390
Marketed since
March 5, 2015
Listing expires
December 31, 2026
Pharmacologic class
Leptin Analog

Active ingredients

Uses, dosage, side effects and warnings for Myalept →

Package NDC codes (1)

Package NDCDescriptionSince
10122-210-021 VIAL, GLASS in 1 CARTON (10122-210-02) / 2.2 mL in 1 VIAL, GLASSMar 5, 2015